Electric field therapy for EGFR-mutated lung cancer
Part of Cancer, Lungs & breathing clinical trials.
This trial tests a wearable device that sends electric fields (called Tumour Treating Fields) to the chest area, which may help slow or stop cancer growth. It is for people with non-small cell lung cancer that has a specific genetic change called EGFR mutation.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be 18 years or older.
- You have been diagnosed with lung cancer (confirmed by biopsy or lab test).
- You have had a genetic test (called next-generation sequencing) done on your tumor sample in a certified lab.
- You have at least one tumor that can be measured on a scan.
- Your life expectancy is at least 3 months, and you are able to take care of yourself (performance status 2 or better).
- You have an EGFR mutation (a specific genetic change in the cancer cells).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a wearable device that uses electric fields (called tumor treating fields) before surgery for early-stage non-small cell lung cancer. The goal is to see if it can help shrink the tumor and improve outcomes for patients.
This study looks at why certain EGFR-positive advanced lung cancers resist third-generation EGFR tablet treatment given as the first treatment. Your body samples and scan results help researchers understand the resistance, which may guide better future care.
This study looks at how EGFR-mutated lung cancer changes over time and tries to find markers that can predict how well you might respond to treatment. You will provide a tumor sample for genetic analysis.
This trial tests a targeted therapy (firmonertinib) combined with standard chemotherapy before surgery, to see if it can shrink tumors and improve outcomes for people with early-stage lung cancer that has a specific EGFR gene change.
This trial tests adding a device that delivers electric fields (Tumor Treating Fields) to standard immunotherapy and chemotherapy for people with advanced non-small cell lung cancer that has not been treated before. It may help slow tumor growth.
This trial tests combining two types of cancer drugs—a targeted pill that attacks a specific mutation in your lung cancer cells, followed by an immunotherapy injection when your tumor stops shrinking. The goal is to see if this combination works better than standard treatment alone.
Hear when a new Non Small Cell Lung Cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.